4.5 Million IU Colistimethate Sodium Injection About
Experience extraordinary antibacterial efficacy with our 4.5 Million IU Colistimethate Sodium Injection, available now at clearance prices for select hospitals. Exclusively manufactured by Oxnord Healthcare, this enviable single-dose vial provides inestimable support in the treatment of life-threatening Gram-negative infections. Supplied as a sterile, lyophilized powder for intravenous injection, its potent formula ensures targeted action in severe bacterial cases. This IP-certified solution is recommended for adult patients and requires physician-directed administration. Secure your exclusive supply-available only by prescription and designed for enviable, extraordinary outcomes.
Versatile Applications Across Critical Environments
4.5 Million IU Colistimethate Sodium Injection is expertly formulated for hospital use against severe Gram-negative infections. Its application areas include intensive care units, surgical wards, and emergency departments. The injectable solution is suitable solely for intravenous administration, ensuring direct treatment at the infection site. The powder form requires reconstitution before use, offering flexibility for medical professionals in plant application or clinical settings, enabling enviable treatment precision for adult patients.
Reliable Export Options and Sample Policies
Our inestimable product serves a wide export market spanning Asia, Africa, and the Middle East. Shipped goods are prepared and dispatched promptly from major Indian FOB ports, ensuring swift delivery. We offer competitive list prices and facilitate sample drop-off for select buyers to evaluate product quality. Our sample policy is designed for transparency and buyer confidence, providing opportunities for evaluation before bulk purchasing. Choose our extraordinary antibacterial injection for reliable, efficient international supply.
FAQ's of 4.5 Million IU Colistimethate Sodium Injection:
Q: How is the 4.5 Million IU Colistimethate Sodium Injection administered?
A: The injection is administered intravenously after reconstitution as directed by a physician, and is suitable only for adult patients in a hospital setting.
Q: What are the primary benefits of using this exclusive Colistimethate Sodium Injection?
A: This highly selective, IP-certified formulation provides extraordinary efficacy against life-threatening Gram-negative bacterial infections, ensuring targeted treatment for critical patients.
Q: When should this injectable solution be considered for patient care?
A: It is recommended for use when confronting severe, hospital-acquired bacterial infections that are resistant to conventional antibiotics, as determined by a healthcare professional.
Q: Where is this product manufactured and exported from?
A: This select injection is manufactured by Oxnord Healthcare in India and exported globally, especially to regions such as Asia, Africa, and the Middle East via major Indian ports.
Q: What precautions should be taken regarding storage and preparation?
A: Store the vial below 25C and ensure proper reconstitution just prior to intravenous administration to maintain sterility and efficacy.
Q: What is the process for obtaining product samples?
A: Eligible buyers can request samples as per our clear sample policy, with drop-off arrangements made prior to confirming a bulk order.